Clonidine and left ventricular function in ten patients with essential hypertension

Area of Science:

• Cardiology
• Pharmacology

Background:

• Essential hypertension is a leading cause of cardiovascular disease.
• Left ventricular hypertrophy is a significant predictor of cardiovascular events.

Purpose of the Study:

• To evaluate the effects of clonidine on left ventricular mass and function in patients with essential hypertension.
• To assess changes in hemodynamic parameters and plasma renin activity (PRA) during clonidine treatment.

Main Methods:

• M-mode echocardiography was used to assess left ventricular mass and function in 10 hypertensive patients.
• Hemodynamic parameters, including blood pressure and peripheral resistance, were monitored.
• Plasma renin activity (PRA) and urinary electrolytes (Na, K) were measured before and after 16 weeks of clonidine treatment (0.15-0.45 mg/day).

Main Results:

• Clonidine significantly reduced systolic and diastolic blood pressure, total peripheral resistance, and left ventricular wall stress.
• Left ventricular mass index decreased significantly, correlating with reduced wall tension and septal thickness.
• Plasma renin activity (PRA) decreased, while 24-h urinary sodium excretion increased.

Conclusions:

• Clonidine effectively reduces blood pressure and left ventricular mass in patients with essential hypertension.
• The observed decrease in left ventricular mass is associated with reduced cardiac workload and afterload.
• Clonidine's impact on the renin-angiotensin system and sodium balance may contribute to its antihypertensive effects.